| Q36540476 | A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens |
| Q35067988 | A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly. |
| Q39600327 | A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma |
| Q33348593 | Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth |
| Q34191283 | Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells |
| Q33712780 | Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma |
| Q54227641 | Association of miR-146a gene polymorphism with risk of nasopharyngeal carcinoma in the central-southern Chinese population. |
| Q37334551 | Beyond HPV: oncomirs as new players in cervical cancer |
| Q24633405 | CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells |
| Q35069646 | Cellular microRNA miR-181b inhibits replication of mink enteritis virus by repression of non-structural protein 1 translation |
| Q41525878 | Comparative miRNA Expression Profile Analysis of Squamous Cell Carcinoma and Peritumoral Mucosa from the Meso- and Hypopharynx |
| Q59357963 | Contribution of Epstein⁻Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma |
| Q34018282 | Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population |
| Q34311065 | Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing |
| Q90182883 | Differential expression analysis comparing EBV uninfected to infected human cell lines identifies induced non-micro small non-coding RNAs |
| Q39344864 | Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2. |
| Q28603492 | Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients |
| Q38667123 | Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases |
| Q28068361 | Epigenetic Impact on EBV Associated B-Cell Lymphomagenesis |
| Q90312408 | Epigenetic Regulation of Innate Immunity by microRNAs |
| Q37962605 | Epigenomic deregulation in the immune system. |
| Q38076138 | Epstein-Barr Virus (EBV)-associated gastric carcinoma |
| Q54982704 | Epstein-Barr Virus EBER Transcripts Affect miRNA-Mediated Regulation of Specific Targets and Are Processed to Small RNA Species. |
| Q36204326 | Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma |
| Q37696106 | Epstein-Barr virus BARF1-induced NFκB/miR-146a/SMAD4 alterations in stomach cancer cells. |
| Q34928776 | Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers |
| Q39766210 | Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b |
| Q24657973 | Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway |
| Q40765681 | Epstein-Barr virus modulates host cell microRNA-194 to promote IL-10 production and B lymphoma cell survival |
| Q37342546 | Epstein-Barr virus, rapamycin, and host immune responses |
| Q24648180 | Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence |
| Q38691897 | Evaluation of miR-146a expression level in macrophages exposed to Candida glabrata |
| Q38111863 | Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses |
| Q35144486 | Genomic sequence matters: a SNP in microRNA-146a can turn anti-apoptotic. |
| Q24611853 | HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling |
| Q35108358 | Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro |
| Q37436158 | Heterogeneous pathways of maternal-fetal transmission of human viruses (review). |
| Q37015390 | How HTLV-1 may subvert miRNAs for persistence and transformation |
| Q39129671 | Hsa-miR-1246, hsa-miR-320a and hsa-miR-196b-5p inhibitors can reduce the cytotoxicity of Ebola virus glycoprotein in vitro |
| Q35964617 | Identification and Analysis of Novel Viral and Host Dysregulated MicroRNAs in Variant Pseudorabies Virus-Infected PK15 Cells |
| Q33825575 | Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes. |
| Q36552431 | Identification of EBV infection in adults with egg specific food allergy |
| Q33575734 | Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways |
| Q24602900 | Influenza A virus infection of human respiratory cells induces primary microRNA expression |
| Q42702857 | Innate immune modulation in EBV infection |
| Q26781552 | Interaction of drugs of abuse and microRNA with HIV: a brief review |
| Q38886770 | Involvement of TLR2-MyD88 in abnormal expression of miR-146a in peripheral blood monocytes of patients with chronic hepatitis C. |
| Q35834474 | Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling. |
| Q36363240 | Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression |
| Q33753956 | Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a |
| Q37096462 | Krüppel-like factor 8 promotes tumorigenic mammary stem cell induction by targeting miR-146a |
| Q91829932 | LMP1-miR-146a-CXCR4 axis regulates cell proliferation, apoptosis and metastasis |
| Q35768502 | Lack of association of miR-146a and Ets-1 gene polymorphisms with Fuchs uveitis syndrome in Chinese Han patients. |
| Q35671861 | Looking at Kaposi's Sarcoma-Associated Herpesvirus-Host Interactions from a microRNA Viewpoint. |
| Q26865123 | MVP and vaults: a role in the radiation response |
| Q39736662 | Major vault protein forms complexes with hypoxia-inducible factor (HIF)-1alpha and reduces HIF-1alpha level in ACHN human renal adenocarcinoma cells |
| Q38953504 | Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis |
| Q58753107 | MiRNA Dysregulation in Childhood Hematological Cancer |
| Q37407582 | MiRNAs and cancer |
| Q42207091 | MicroRNA expression in Epstein-Barr virus-associated post-transplant smooth muscle tumours is related to leiomyomatous phenotype |
| Q36745742 | MicroRNA in TLR signaling and endotoxin tolerance. |
| Q37067623 | MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes |
| Q39762149 | MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells |
| Q24610098 | MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation |
| Q34686537 | MicroRNA miR-320a and miR-140 inhibit mink enteritis virus infection by repression of its receptor, feline transferrin receptor |
| Q34772318 | MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases |
| Q36530696 | MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma |
| Q26830890 | MicroRNA-146a: A Dominant, Negative Regulator of the Innate Immune Response |
| Q35764627 | MicroRNA: implications in HIV, a brief overview |
| Q40168335 | MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity |
| Q37255242 | MicroRNAs--micro in size but macro in function |
| Q37223449 | MicroRNAs: new regulators of immune cell development and function |
| Q37844405 | MicroRNAs: the fine-tuners of Toll-like receptor signalling |
| Q38988815 | NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms |
| Q37693416 | Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas. |
| Q33951715 | Pharmacological studies of the mechanism and function of interleukin-1beta-induced miRNA-146a expression in primary human airway smooth muscle. |
| Q37083534 | Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer |
| Q35137238 | Presenilin 2 influences miR146 level and activity in microglia |
| Q21136075 | Regulation of miRNA transcription in macrophages in response to Candida albicans |
| Q24647397 | Reticuloendotheliosis virus strain T induces miR-155, which targets JARID2 and promotes cell survival |
| Q34206105 | Retracted: Identification of XMRV Infection-Associated microRNAs in Four Cell Types in Culture |
| Q36411230 | Specific Roles of MicroRNAs in Their Interactions with Environmental Factors |
| Q34711793 | The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8. |
| Q34267599 | The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells |
| Q38597238 | The Latent Membrane Protein 1 (LMP1). |
| Q37997552 | The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer |
| Q34253049 | The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells |
| Q39182339 | The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer |
| Q37013789 | The role of microRNAs in Epstein-Barr virus latency and lytic reactivation |
| Q36932335 | Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression |
| Q37151661 | Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation |
| Q33889404 | Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. |
| Q37036921 | Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome |
| Q35677504 | Upregulation of microRNA-146a by hepatitis B virus X protein contributes to hepatitis development by downregulating complement factor H. |
| Q34394771 | Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses |
| Q47551999 | Viruses as key modulators of the TGF-β pathway; a double-edged sword involved in cancer |
| Q33762630 | miR-127-5p negatively regulates enterovirus 71 replication by directly targeting SCARB2 |
| Q37327560 | miR-146a-5p circuitry uncouples cell proliferation and migration, but not differentiation, in human mesenchymal stem cells |
| Q38960502 | miR-223 inhibits dengue virus replication by negatively regulating the microtubule-destabilizing protein STMN1 in EAhy926 cells |
| Q34504522 | miRNAs in the pathogenesis of oncogenic human viruses |
| Q33742946 | microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma |